Quantification of low amounts of antibody side-products
AssigneeHoffmann-La Roche Inc.
InventorsLaurent LARIVIERE, Tilman SCHLOTHAUER, Christian SPICK, Adrian ZWICK
Life of this patent
Estimating the term…
Loading patent…
AssigneeHoffmann-La Roche Inc.
InventorsLaurent LARIVIERE, Tilman SCHLOTHAUER, Christian SPICK, Adrian ZWICK
Estimating the term…
The current invention is directed to a method for determining homodimeric avid-binding side-products of a bispecific antibody in a sample comprising the correctly assemble heterodimeric affine-binding bispecific antibody and the mis-assembled homodimeric avid-binding side-product of the bispecific antibody using surface plasmon resonance, wherein the correctly assembled heterodimeric affine-binding bispecific antibody comprises one or more binding site for a first antigen and one or more binding sites for a second antigen, wherein the mis-assembled homodimeric avid-binding side-product of the bispecific antibody comprises two or more binding sites to the first antigen but at least more than the correctly assembled bispecific antibody, wherein the correctly assembled bispecific antibody is a heterodimer and the mis-assembled bispecific antibody is a homodimer, wherein the presence of the homodimeric avid-binding side-product is determined if residual binding, i.e. an increased SPR signal, can be determined in the dissolution phase of the SPR analysis.
A method for determining avid-binding side-products of a bispecific antibody in a sample comprising correctly assembled bispecific antibody and one or more avid-binding side-product of the bispecific antibody using surface plasmon resonance,
Dependencies are inferred from the claim text.